Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway

BACKGROUND: IL-1β has been shown to play a pivotal role in autoimmunity. Cysteinyl aspartate-specific proteinase-1 (caspase-1) inhibitor may be an important drug target for autoimmune diseases. However, the effects of caspase-1 inhibitor on myasthenia gravis (MG) remain undefined. METHODS: To invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Cong-Cong, Li, Heng, Zhang, Min, Li, Xiao-Li, Yue, Long-Tao, Zhang, Peng, Zhao, Yue, Wang, Shan, Duan, Ruo-Nan, Li, Yan-Bin, Duan, Rui-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470006/
https://www.ncbi.nlm.nih.gov/pubmed/26071315
http://dx.doi.org/10.1186/s12974-015-0334-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470006/
https://www.ncbi.nlm.nih.gov/pubmed/26071315
http://dx.doi.org/10.1186/s12974-015-0334-4

Ejemplares similares